Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dissecting the World's Biggest Diabetes Drug Stock
Motley Fool
Saturday, July 6, 2013 - 11:56am
tags:
Novo Nordisk
FDA Accepts The Medicines Co.'s NDA
Yahoo/Zacks
Saturday, July 6, 2013 - 11:56am
tags:
Cangrelor, Medicines Company, anti-platelet
Vivus, activist investor claim support in proxy battle
Reuters
Saturday, July 6, 2013 - 11:54am
tags:
Vivus, obesity, weight loss, Qsymia
Arena Sales Picking Up
Seeking Alpha
Saturday, July 6, 2013 - 11:53am
tags:
Arena Pharmaceutical, Belviq, obesity, weight loss
GTX Incorporated: Its 'Other' Drug, Capesaris
Seeking Alpha
Saturday, July 6, 2013 - 11:52am
tags:
GTx, Capesaris, prostate cancer
How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?
Insider Monkey
Friday, July 5, 2013 - 1:10pm
tags:
ONYX Pharmaceuticals, M&A, Amgen
A Small-Cap Pharmaceutical Company With 2014 in Its Sights
Motley Fool
Friday, July 5, 2013 - 12:00pm
tags:
Medicines Company, Angiomax
FDA Proposes Rule To Allow Generic Drugmakers To Change Labeling
Pharmalot
Friday, July 5, 2013 - 10:47am
tags:
FDA, generics, labeling
Sarepta Therapeutics shares slip after company announces at-the-market offering of shares
stock offering
Friday, July 5, 2013 - 10:43am
tags:
Sarepta Therapeutics
Top Vivus shareholder says proxy firm ISS backs 3 of 9 board nominees
Reuters
Friday, July 5, 2013 - 10:41am
tags:
Vivus
Coronado Biosciences Reuniting Old Friends
Seeking Alpha
Friday, July 5, 2013 - 10:40am
tags:
Coronado Biosciences, CNDO-201, CNDO-109, Crohn's Disease, Multiple Myeloma, acute myeloid leukemia
Johnson & Johnson, Merck Facing Biosimilar Threat
Seeking Alpha
Friday, July 5, 2013 - 10:35am
tags:
Merck, JNJ, biosimilars, Hospira, Celltrion
Watch Out for These 3 Biotech Companies
Motley Fool
Thursday, July 4, 2013 - 11:23am
tags:
Biogen Idec, Biocad, Amgen, M&A, Celgene, MorphoSys, Tecfidera
Orexo Wins U.S. Backing for Opioid-Addiction Tablet
Bloomberg
Thursday, July 4, 2013 - 11:16am
tags:
Orexo, opiod addiciton, FDA, Zubsolv
In Pursuit of Healthcare, Buying Time - A 21st Century Declaration
Forbes
Thursday, July 4, 2013 - 11:15am
tags:
Warren Buffett, GSK, Affordable Care Act, JNJ, DaVita
How An Improved Damages Award Against SIGA Would Affect PharmAthene's Valuation
Seeking Alpha
Thursday, July 4, 2013 - 11:13am
tags:
SIGA technologies, PharmAthene
Mallinckrodt Pharmaceuticals: An Under-Followed Spin-Off With Attractive Upside
Seeking Alpha
Thursday, July 4, 2013 - 11:12am
tags:
spinoffs, Mallinckrodt, Covidien
SEC alleges insider trading in Onyx ahead of Amgen news
Reuters
Wednesday, July 3, 2013 - 10:08pm
tags:
SEC, insider trading, ONYX Pharmaceuticals, Amgen, M&A
Medicare Limits Coverage of Lilly’s Drug for Brain Scans
Bloomberg
Wednesday, July 3, 2013 - 10:06pm
tags:
Medicare, Eli Lilly, Alzheimer's disease
Medtech trends: The most talked about device makers in June 2013
Mass Device
Wednesday, July 3, 2013 - 3:30pm
tags:
Medtech, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.